Cintas Corp Q4 2022 Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Ashish Sabadra - RBC Capital Markets, Research Division - Analyst : I just wanted to focus on the health care, government and education vertical, those 3 key verticals that were a key area of focus. How is the progress on that front? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. JULY 14, 2022 / 2:00PM, CTAS.OQ - Q4 2022 Cintas Corp Earnings Call And then maybe a more broader questions around the economic sensitivity of your end market. Just wanted to follow up on the earlier question, like how much of the revenue is really generated from more sensitive end market versus more recession-resilient end markets? Any color on that front will be helpful.

Question: Ashish Sabadra - RBC Capital Markets, Research Division - Analyst : That's very helpful color. And maybe just a quick one on the -- follow-up on the health care. I know the last disclosure was -- it was, I think, almost 7% of the revenue with the opportunity to be 10% of the revenue in the midterm. I was wondering if it's possible to provide any update on that front, particularly on the health care side?

Question: Ashish Sabadra - RBC Capital Markets, Research Division - Analyst : That's great. Congrats on the strong momentum in the business.